Related Experiment Video
Updated: Aug 25, 2026
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Comparison between segmentectomy and larger resection of stage IA non-small cell lung carcinoma
A Campione1, T Ligabue, L Luzzi
1Department of Thoracic and Cardiovascular Surgery, University Hospital Le Scotte, Siena, Italy.
Aim:
Stage IA non small cell lung carcinoma (NSCLC) represents early cancer and is best treated by surgery. The frequency of recurrence and new primary cancer varies from one report to another while the role of sublobar resection is still debated.
Methods:
We retrospectively reviewed 121 consecutive patients with pathological stage IA after radical surgery.
Results:
In stage IA NSCLC 1-, 3-, 5-year survival rates were 89%, 76% and 66%. Nearly half of the deaths were unrelated to the original cancer. From statistical analysis we did not find any factor indicative of a better prognosis. We did not find any difference in survival between histologic types. Segmentectomy did not show a worse survival rate compared with larger resection.
Conclusion:
Survival is neither influenced by the type of resection nor by the histologic types in stage IA. However, we noticed a high incidence of local recurrence, segmentectomy could be a viable choice in patients with cardiopulmonary impairment.
